An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
ABSTRACT Influenza virus infections are a global public health problem, with a significant impact of morbidity and mortality from both annual epidemics and pandemics. The current strategy for preventing annual influenza is to develop a new vaccine each year against specific circulating virus strains...
Saved in:
Main Authors: | Louis M. Schwartzman, Andrea L. Cathcart, Lindsey M. Pujanauski, Li Qi, John C. Kash, Jeffery K. Taubenberger |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/cea1cc51d5b54d1b8b118a8c21c76d8d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contemporary Avian Influenza A Virus Subtype H1, H6, H7, H10, and H15 Hemagglutinin Genes Encode a Mammalian Virulence Factor Similar to the 1918 Pandemic Virus H1 Hemagglutinin
by: Li Qi, et al.
Published: (2014) -
Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
by: Penghui Yang, et al.
Published: (2012) -
Influenza Viruses: Breaking All the Rules
by: Jeffery K. Taubenberger, et al.
Published: (2013) -
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza.
by: Nathalie Landry, et al.
Published: (2010) -
Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
by: Mariana Baz, et al.
Published: (2015)